Maxim raises its Nutanix target to 32% upside

Maxim raises its Nutanix (NASDAQ:NTNX) price target from $54 to $71, a 34% upside to yesterday’s close.

Firm notes that the $3B FY21 billings target presented at the investor day is 39% above analyst estimates but looks conservative from many angles.

The target increase comes as Maxim raises its long-term sales productivity forecast.


Nutanix shares are up 0.9% premarket to $53.49.

Previously: Needham raises its Nutanix target to 18.5% upside (March 13)